The price of this share is at 2,10$, NRX Pharmaceuticals Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are James Brandon (Chief Financial Officer), Randy Guggenheimer (Chief Business Officer), Robert Besthof (Chief Commercial & Patent Officer, Head-Operations) and its address is 2645 N. FEDERAL HIGHWAY SUITE 230, DELRAY BEACH, Florida, 33483, United States.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 2,23$ moving between 2,01$ and 2,44$, it is a notable difference that allows quick purchases and sales.
He earns an annual income of desconocido.
The last value we have registered for the opening is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
